Conditions: Bladder Cancer; Nerve Sheath Tumor; Nerve Sheath Tumors; Solid Tumor Malignancies; Solid Tumor Cancer; Solid Tumor Neoplasms; Advanced Solid Tumor; Bladder Neoplasm; Nerve Sheath Neoplasms; Nerve Sheath Tumor, Nos; Solid Tumor, Adult; Solid Carcinoma
Interventions: Drug: [89Zr]DFO-YS5; Procedure: Positron Emission Tomography (PET)-Magnetic resonance imaging (MRI); Procedure: Positron Emission Tomography (PET)-Computerized tomography (CT)
Sponsors: Robert Flavell, MD, PhD; Kyntra Bio; Fortis Therapeutics, Inc.
Not yet **RECRUITING NOW**
Interventions: Drug: [89Zr]DFO-YS5; Procedure: Positron Emission Tomography (PET)-Magnetic resonance imaging (MRI); Procedure: Positron Emission Tomography (PET)-Computerized tomography (CT)
Sponsors: Robert Flavell, MD, PhD; Kyntra Bio; Fortis Therapeutics, Inc.
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.